Table 1.
Baseline demographic data and clinical characteristics of the patients
| Characteristics | MTX + HCQ (Group 1) | LEF (Group 2) | P value |
|---|---|---|---|
| Number of patients recruited | 30 | 30 | |
| Number of patients at follow-up | 30 | 29 | |
| Female sex (%) | 90 | 86.66 | |
| Age (years) | 48.24 ± 11.44 | 49.33 ± 11.381 | 0.683 |
| Total joint count | 19.03 ± 10.61 | 19.86 ± 9.22 | 0.669 |
| Swollen joint count | 8.56 ± 9.94 | 10.62 ± 9.90 | 0.306 |
| Erythrocyte | 40.70 ± 30.62 | 42.82 ± 23.90 | 0.569 |
| sedimentation rate | |||
| Pain assessment on | 82.50 ± 12.52 | 88.88 ± 6.08 | 0.064 |
| Visual Analog Scale | |||
| Disease Activity Score | 6.42 ± 1.74 | 6.91 ± 1.19 | 0.453 |
Data shown is mean ± SD;
*Statistically significant; Mtx = Methotrexate; HCQ = hydroxychloroquine; LEF = leflunomide.